🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
The purpose of the study is to evaluate the single-dose pharmacokinetics (P...
Status
Terminated
Location
PRA Health Sciences Onderzoekscentrum Groningen, locatie Martini
Start Date
2020-01-23
Trial ID
NCT04236453
The primary objectives of Cohort 1 are to evaluate the steady state pharmac...
Status
Completed
Location
Miller's Children Hospital
Start Date
2013-05-06
Trial ID
NCT01854775
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics and relative ...
Status
Completed
Location
Multiple Locations
Start Date
2015-06-01
Trial ID
NCT02475135
This study will evaluate the non-inferiority of Stribild® (elvitegravir/cob...
Status
Completed
Location
Spectrum Medical Group
Start Date
2011-11
Trial ID
NCT01475838
The purpose of the study is to evaluate the pharmacokinetic (PK) and safety...
Status
Completed
Location
Souseikai Hakata Clinic
Start Date
2017-04-14
Trial ID
NCT03123848
Treatments Being Tested
This study is being conducted to determine if the uptake of anti-HIV medica...
Status
Completed
Location
Emory University
Start Date
2018-04-27
Trial ID
NCT03472963
Treatments Being Tested
The purpose of this study is to evaluate the single-dose pharmacokinetics a...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02578550
The purpose of this study is to demonstrate the effectiveness of Symtuza® i...
Status
Completed
Location
The Crofoot Research Center, Inc.
Start Date
2021-09-01
Trial ID
NCT04388904
Treatments Being Tested
This is a drug-drug interaction study in volunteers to evaluate the effect ...
Status
Completed
Location
Celerion, Inc.
Start Date
2022-09-09
Trial ID
NCT05692570
Treatments Being Tested